SPECIAL TOPIC
Palladium-Catalyzed p-Allylic Sulfonylation in Water
MS (EI): m/z (%) = 237 (3, M+ + H), 143 (99), 95 (bp).
1963
13C NMR (CDCl3): d = 159.8, 138.6, 133.6, 130.9, 129.0, 128.5,
127.8, 127.6, 114.0, 112.5, 60.5, 55.2.
cis-5-Methoxycarbonylcyclohex-2-enyl Phenyl Sulfone (5)
MS (EI): m/z (%) = 288 (10, M+), 197 (9), 115 (bp), 51 (67).
IR (ATR): 2979, 1731, 1085 cm–1.
3-(Phenylsulfonyl)-1,3-diphenylprop-2-ene (3e)
1H NMR (CDCl3): d = 7.87 (d, J = 7.8 Hz, 2 H), 7.67 (t, J = 7.8 Hz,
1 H), 7.57 (t, J = 7.8 Hz, 2 H), 6.05–6.02 (m, 1 H), 5.90 (d, J = 10.2
Hz, 1 H), 3.92–3.89 (m, 1 H), 3.69 (s, 3 H), 2.57–2.53 (m, 1 H),
2.40–2.38 (m, 1 H), 2.33–2.25 (m, 1 H), 2.10–2.02 (m, 1 H), 5.67
(d, J = 10.3 Hz, 1 H), 3.99 (br s, 1 H), 3.72 (s, 3 H), 2.67 (dddd,
J = 12.2, 9.7, 6.4, 2.4 Hz, 1 H), 2.42–2.24 (m, 3 H), 1.72 (ddd,
J = 12.3, 12.3, 12.3 Hz, 1 H).
13C NMR (CDCl3): d = 174.1, 136.3, 133.8, 132.5, 129.1, 129.0,
118.9, 62.7, 52.1, 38.1, 27.2, 25.5.
MS (EI): m/z (%) = 280 (0.3, M+), 139 (16), 79 (bp), 51 (30).
IR (ATR): 3060, 1142, 1082 cm–1.
1H NMR (CDCl3): d = 7.65 (d, J = 7.3 Hz, 2 H), 7.54 (t, J = 7.3 Hz,
1 H), 7.39 (t, J = 7.3 Hz, 2 H), 7.35–7.25 (m, 10 H), 6.56 (dd,
J = 15.6, 8.7 Hz, 1 H), 6.49 (d, J = 15.6 Hz, 1 H), 4.81 (d, J = 8.7
Hz, 1 H).
13C NMR (CDCl3): d = 156.4, 155.6, 154.1, 150.5, 148.0, 147.6,
147.2, 147.0, 146.9, 146.9, 146.8, 145.0, 138.2, 93.7.
MS (EI): m/z (%) = 334 (0.5, M+), 191 (42), 115 (bp), 91 (41).
Geranyl Phenyl Sulfone (3f)
Palladium-Catalyzed Asymmetric Allylic Substitution of Cy-
clic Allyl Esters with Sodium Benzenesulfinate; (S)-3-(Phenyl-
sulfonyl)cyclohept-1-ene [(S)-3k]; Typical Procedure
IR (ATR): 2918, 1446, 1294, 1144, 1085 cm–1.
1H NMR (CDCl3): d = 7.88–7.85 (m, 2 H), 7.65–7.61 (m, 1 H),
7.55–7.51 (m, 2 H), 5.18 (t, J = 8.0 Hz, 1 H), 5.02 (m, 1 H), 3.80 (d,
J = 8.0 Hz, 2 H), 2.18–1.94 (m, 4 H), 1.68 (s, 3 H), 1.58 (s, 3 H),
1.31 (s, 3 H).
13C NMR (CDCl3): d = 146.3, 138.6, 133.4, 132.0, 128.9, 128.5,
123.4, 110.2, 56.0, 39.6, 26.1, 25.6, 17.6, 16.1.
To a mixture of the catalyst 6 (89 mg, 0.025 mmol) and methyl cy-
cloheptenyl carbonate (2k; 85.0 mg, 0.5 mmol) in H2O (2.0 mL)
was added sodium benzenesulfinate (150 mg, 0.75 mmol) and the
mixture was stirred at 25 °C for 1 h. The mixture was filtered and
the recovered resin beads were rinsed with EtOAc (3 mL). The
EtOAc layer was separated and the aqueous layer was extracted
with EtOAc (5 mL). The combined EtOAc extracts were washed
with brine (2 mL) and dried (MgSO4). The solvent was evaporated
and the residue was chromatographed on silica gel (hexane–
MS (EI): m/z (%) = 169 (1, M+ – O2Ph), 141 (10), 77 (91), 41 (bp).
Linalyl Phenyl Sulfone (3h)
IR (ATR): 2918, 1446, 1294, 1144, 1085 cm–1.
19
EtOAc, 2:1) to give 65 mg (84%) of (S)-3k; [a]D –145 (c 1.0,
1H NMR (CDCl3): d = 7.77 (d, J = 8.3 Hz, 2 H), 7.59 (d, J = 8.3 Hz,
1 H), 7.48 (t, J = 8.3 Hz, 2 H), 5.89 (dd, J = 17.5, 10.7 Hz, 1 H), 5.33
(d, J = 10.7 Hz, 1 H), 5.03 (d, J = 17.5 Hz, 1 H), 5.01 (m, 1 H),
1.96–1.83 (m, 4 H), 1.63 (s, 3 H), 1.52 (s, 3 H), 1.34 (s, 3 H).
13C NMR (CDCl3): d = 135.1, 133.4, 130.7, 128.8, 128.2, 123.0,
120.4, 110.2, 68.2, 32.7, 25.5, 22.4, 17.6, 16.1.
CH2Cl2); ee 71% {Lit.15 [a]D25 –89.6 (c 3.84, CH2Cl2) for (S)-3k of
94% ee}. The enantiomeric excess was determined by HPLC anal-
ysis using a chiral stationary phase column [Chiralcel OD-H (500
mm); eluent: n-hexane–i-PrOH, 9:1; flow rate: 0.5 mL/min; tR:
major isomer 59 min and minor isomer 62 min].
Spectral data of (S)-3k were identical with that of 3k given above.
MS (EI): m/z (%) = 169 (1, M+ – O2Ph), 141 (10), 77 (91), 41 (bp).
(S)-3i
[a]D20 –179.9 (c 0.45, CH2Cl2); ee 45% {Lit.15 [a]D20 –216.6 (c 1.56,
CH2Cl2) for (S)-3i of 98% ee}. The enantiomeric excess was deter-
mined by HPLC analysis using a chiral stationary phase column
[Chiralcel OD-H (500 mm); eluent: n-hexane–i-PrOH, 9:1; flow
rate: 0.5 mL/min; tR: major isomer 77 min and minor isomer 82
min].
3-(Phenylsulfonyl)cyclopent-1-ene (3i)
IR (ATR): 2936, 1302, 1138, 1084 cm–1.
1H NMR (CDCl3): d = 7.88 (d, J = 7.3 Hz, 2 H), 7.65 (t, J = 7.3 Hz,
1 H), 7.54 (t, J = 7.3 Hz, 2 H), 6.12–6.10 (m, 1 H), 5.68–5.66 (m, 1
H), 4.29–4.27 (m, 1 H), 2.39–2.13 (m, 4 H).
13C NMR (CDCl3): d = 140.2, 137.5, 133.5, 129.0, 128.8, 123.7,
72.3, 31.8, 24.4.
Spectral data of (S)-3i were identical with that of 3i given above.
MS (EI): m/z (%) = 209 (0.1, M+ + H), 143 (6), 67 (bp).
(S)-3j
20
20
[a]D –60.0 (c 0.4, CH2Cl2); ee 33% {Lit.15 [a]D –136.8 (c 3.84,
CH2Cl2) for (S)-3j of 98% ee}. The enantiomeric excess was deter-
mined by HPLC analysis using a chiral stationary phase column
[Chiralcel AD-H (500 mm); eluent: n-hexane–i-PrOH, 9:1; flow
rate: 0.5 mL/min; tR: major isomer 68 min and minor isomer 71
min].
3-(Phenylsulfonyl)cyclohex-1-ene (3j)
IR (ATR): 2938, 1302, 1084 cm–1.
1H NMR (CDCl3): d = 7.88 (d, J = 7.8 Hz, 2 H), 7.65 (t, J = 7.8 Hz,
1 H), 7.55 (t, J = 7.8 Hz, 2 H), 6.10–6.07 (m, 1 H), 5.79–5.77 (m, 1
H), 3.77–3.75 (m, 1 H), 2.01–1.73 (m, 5 H), 1.53–1.46 (m, 1 H).
13C NMR (CDCl3): d = 137.3, 135.2, 133.5, 129.1, 128.9, 118.4,
61.7, 24.3, 22.6, 19.4.
Spectral data of (S)-3j were identical with that of 3j given above.
MS (EI): m/z (%) = 223 (33, M+ + H), 143 (99), 77 (bp).
Acknowledgment
This work was supported by the CREST program, sponsored by the
JST. We also thank the MEXT (Scientific Research on Priority
Areas, No. 460) for partial financial support of this work.
3-(Phenylsulfonyl)cyclohept-1-ene (3k)
IR (ATR): 2926, 1303, 1084 cm–1.
1H NMR (CDCl3): d = 7.91 (d, J = 8.2 Hz, 2 H), 7.65 (t, J = 8.2 Hz,
1 H), 7.56 (t, J = 8.2 Hz, 2 H), 6.04–5.99 (m, 1 H), 5.82–5.79 (m, 1
H), 3.86–3.83 (m, 1 H), 2.23–2.19 (m, 2 H), 2.08–2.20 (m, 2 H),
1.72–1.58 (m, 3 H), 1.46–1.44 (m, 1 H).
13C NMR (CDCl3): d = 137.8, 136.8, 133.5, 129.0, 128.9, 123.7,
66.2, 27.9, 27.8, 26.8, 25.9.
References
(1) For reviews, see: (a) Fuchs, P. L.; Braish, T. F. Chem. Rev.
1986, 86, 903. (b) Roberts, D. W.; Williams, D. L.
Tetrahedron 1987, 43, 1027.
Synthesis 2008, No. 12, 1960–1964 © Thieme Stuttgart · New York